This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Acupuncture for Patients With Function Dyspepsia

This study has been completed.
Sponsor:
Collaborators:
Hunan University of Traditional Chinese Medicine
Chongqing Medical University
Information provided by (Responsible Party):
Chengdu University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT01671670
First received: August 21, 2012
Last updated: November 25, 2014
Last verified: November 2014
  Purpose

Hypothesis: Acupuncture is efficacious and safe for patients with functional dyspepsia

Design:

  • A single blind randomized controlled trial
  • 200 participants will be included
  • Two arms: acupuncture and sham acupuncture group

Condition Intervention Phase
Functional Dyspepsia Postprandial Distress Syndrome Other: acupuncture Other: sham acupuncture Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Phase III Study of Acupuncture for Patients With Functional Dyspepsia

Resource links provided by NLM:


Further study details as provided by Chengdu University of Traditional Chinese Medicine:

Primary Outcome Measures:
  • The proportion of participants reporting complete absence of dyspeptic symptoms [ Time Frame: at 16 weeks after inclusion ]

Secondary Outcome Measures:
  • validated Leeds Dyspepsia Questionnaire [ Time Frame: 4, 8, 16, 20, 24 weeks after inclusion ]
  • Nepean dyspepsia index [ Time Frame: 4, 8, 16, 20, 24 weeks after inclusion ]
  • adverse events in each group [ Time Frame: 4 weeks after inclusion ]

Enrollment: 200
Study Start Date: September 2012
Study Completion Date: November 2014
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: acupuncture group
use traditional acupuncture to treat functional dyspepsia
Other: acupuncture
In this group, acupuncture is given according to traditional acupuncture theories.
Other Name: use hwato acupuncture needles
Sham Comparator: sham acupuncture group
use penetrating sham acupuncture to manage functional dyspepsia
Other: sham acupuncture
Sham acupuncture points will be used in this trial, with needle penetration.
Other Name: verum acupuncture

Detailed Description:
Aim: to clarify the efficacy and safety of acupuncture for patients with functional dyspepsia Design: A single blind randomized controlled trial will be performed in Chengdu, Hunan and Chongqing province. Two hundred participants will be randomly assign to acupuncture and sham acupuncture group. Each participants will receive 20 sessions of acupuncture in 4 weeks, with a duration of 30 minutes in a session. The primary outcome is Patients' global assessments of efficacy in 16 weeks after inclusion. Secondary outcomes include validated Leeds Dyspepsia Questionnaire, Nepean dyspepsia index, etc.
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Consistent with the diagnostic criteria of functional dyspepsia.
  • Age of a subject is older than 18 and is younger than 65.(including 18 and 65)
  • Include postprandial distress syndrome.
  • Did not take any gastroenteric dynamic drugs in the last 15 days, and did not take part in any clinical trial.
  • Informed consent is signed by a subject or his lineal relation.

Exclusion Criteria:

  • Patients with any contraindications of Itopride.
  • Patients who are unconscious, psychotic.
  • Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding.
  • With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on.
  • Pregnant women or women in lactation.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01671670

Locations
China, Sichuan
Chengdu University of TCM
Chengdu, Sichuan, China, 610075
Sponsors and Collaborators
Chengdu University of Traditional Chinese Medicine
Hunan University of Traditional Chinese Medicine
Chongqing Medical University
Investigators
Study Chair: Fan-rong Liang, MD Chengdu University of TCM
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Chengdu University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier: NCT01671670     History of Changes
Other Study ID Numbers: 2012CB518501-3
2012CB518501 ( Other Grant/Funding Number: The Chinese Ministry of science and technology )
Study First Received: August 21, 2012
Last Updated: November 25, 2014

Keywords provided by Chengdu University of Traditional Chinese Medicine:
Functional dyspepsia
postprandial distress syndrome

Additional relevant MeSH terms:
Dyspepsia
Gastritis
Signs and Symptoms, Digestive
Signs and Symptoms
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Stomach Diseases

ClinicalTrials.gov processed this record on July 19, 2017